What does MED GEUS-DECERF do?

MED GEUS-DECERF is a general practice in Chastre. Private Limited, started on 7 January 2011, 1 establishment.

What is the address of MED GEUS-DECERF?

The registered office of MED GEUS-DECERF is located at Rue Gaston Delvaux 100, 1450 Chastre.

Is MED GEUS-DECERF still active?

Yes. According to the CBE (30 October 2026) MED GEUS-DECERF is active, legal situation “Normale toestand”, started on 7 January 2011.

Is MED GEUS-DECERF registered on Peppol?

Yes, MED GEUS-DECERF is registered on the Peppol network with ID 0208:0832964833.

What is the enterprise number of MED GEUS-DECERF?

The enterprise number of MED GEUS-DECERF is BE0832964833.

When was MED GEUS-DECERF founded?

MED GEUS-DECERF was founded on 7 January 2011.

Who are the directors of MED GEUS-DECERF?

According to the 2025 annual accounts, the directors of MED GEUS-DECERF are: Christophe Geus, Laurence Decerf.

Is MED GEUS-DECERF a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 January 2011; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MED GEUS-DECERF make in 2025?

MED GEUS-DECERF posted a profit after taxes of € 66,716 in financial year 2025.

What is the revenue of MED GEUS-DECERF?

As a small company, MED GEUS-DECERF is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 101,668.

MED GEUS-DECERF (Private Limited) - Chastre

Dossier MED GEUS-DECERF, printed on 30 October 2026 from databakkes.be/en/0832964833/med-geus-decerf. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MED GEUS-DECERF from Chastre, company number BE0832964833, closed financial year 2025 with a result of € 66,716 after tax. For that financial year MED GEUS-DECERF recorded a gross margin of € 101,668 and equity of € 92,193. Compared with financial year 2024, the result moved from € 53,449 to € 66,716. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 28, 2026.

What it is worth Growing

€ 92,193

▲ 41% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 66,716

▲ 25% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 137,627

▲ 28% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 40,000 paid out

60 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 10,023

▼ 9% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 15,425

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 7,169

▼ 35% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 24,017

▼ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 95,001 Gross margin 2022: € 95,001 First fiscal year in the series	€ 63,963 Gross margin 2023: € 63,963 ▼ 33% vs 2022 (€ 95,001) Unfavourable step	€ 62,004 Gross margin 2024: € 62,004 ▼ 3% vs 2023 (€ 63,963) Unfavourable step	€ 101,668 Gross margin 2025: € 101,668 ▲ 64% vs 2024 (€ 62,004) Favourable step	▲ 64%
Profit after taxes	€ 62,416 Profit after taxes 2022: € 62,416 First fiscal year in the series	€ 39,154 Profit after taxes 2023: € 39,154 ▼ 37% vs 2022 (€ 62,416) Unfavourable step	€ 53,449 Profit after taxes 2024: € 53,449 ▲ 37% vs 2023 (€ 39,154) Favourable step	€ 66,716 Profit after taxes 2025: € 66,716 ▲ 25% vs 2024 (€ 53,449) Favourable step	▲ 25%
Equity	€ 66,174 Equity 2022: € 66,174 First fiscal year in the series	€ 65,528 Equity 2023: € 65,528 ▼ 1% vs 2022 (€ 66,174) Unfavourable step	€ 65,476 Equity 2024: € 65,476 Unchanged (€ 65,528) Unfavourable step	€ 92,193 Equity 2025: € 92,193 ▲ 41% vs 2024 (€ 65,476) Favourable step	▲ 41%
Total debts	€ 95,767 Total debts 2022: € 95,767 First fiscal year in the series	€ 92,680 Total debts 2023: € 92,680 ▼ 3% vs 2022 (€ 95,767) Favourable step	€ 105,193 Total debts 2024: € 105,193 ▲ 14% vs 2023 (€ 92,680) Unfavourable step	€ 98,011 Total debts 2025: € 98,011 ▼ 7% vs 2024 (€ 105,193) Favourable step	▼ 7%
Cash	€ 120,649 Cash 2022: € 120,649 First fiscal year in the series	€ 119,169 Cash 2023: € 119,169 ▼ 1% vs 2022 (€ 120,649) Unfavourable step	€ 107,268 Cash 2024: € 107,268 ▼ 10% vs 2023 (€ 119,169) Unfavourable step	€ 137,627 Cash 2025: € 137,627 ▲ 28% vs 2024 (€ 107,268) Favourable step	▲ 28%
Retained profit	€ 59,974 Retained profit 2022: € 59,974 First fiscal year in the series	€ 59,328 Retained profit 2023: € 59,328 ▼ 1% vs 2022 (€ 59,974) Unfavourable step	€ 59,276 Retained profit 2024: € 59,276 Unchanged (€ 59,328) Unfavourable step	€ 85,993 Retained profit 2025: € 85,993 ▲ 45% vs 2024 (€ 59,276) Favourable step	▲ 45%
Dividend	€ 45,000 Dividend 2022: € 45,000 First fiscal year in the series	€ 39,800 Dividend 2023: € 39,800 ▼ 12% vs 2022 (€ 45,000) Unchanged	€ 53,500 Dividend 2024: € 53,500 ▲ 34% vs 2023 (€ 39,800) Unchanged	€ 40,000 Dividend 2025: € 40,000 ▼ 25% vs 2024 (€ 53,500) Unchanged	▼ 25%
Bank debt	€ 15,273 Bank debt 2022: € 15,273 First fiscal year in the series	€ 15,360 Bank debt 2023: € 15,360 ▲ 1% vs 2022 (€ 15,273) Unfavourable step	€ 15,360 Bank debt 2024: € 15,360 Unchanged (€ 15,360) Unchanged	€ 15,425 Bank debt 2025: € 15,425 Unchanged (€ 15,360) Unfavourable step
Balance sheet total	€ 161,941 Balance sheet total 2022: € 161,941 First fiscal year in the series	€ 158,208 Balance sheet total 2023: € 158,208 ▼ 2% vs 2022 (€ 161,941) Unchanged	€ 170,669 Balance sheet total 2024: € 170,669 ▲ 8% vs 2023 (€ 158,208) Unchanged	€ 190,203 Balance sheet total 2025: € 190,203 ▲ 11% vs 2024 (€ 170,669) Unchanged	▲ 11%

Key figures of MED GEUS-DECERF, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MED GEUS-DECERF?

What happened at MED GEUS-DECERF in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 28, 2026 New annual accounts for financial year 2025: profit of € 66,716 (▲ 25% vs 2024). Source: NBB ↗
Jan 19, 2011 New establishment in Chastre. KBO
Jan 7, 2011 Start of the company according to the CBE. KBO

In short

From € 62,416 profit in 2022 to € 66,716 profit in 2025.

Paid € 80,455 in corporate taxes since 2022.

Best year ever: 2025, with € 66,716 profit.

Paid out € 178,300 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Christophe Geus Laurence Decerf

MED GEUS-DECERF

Behind MED GEUS-DECERF are Christophe Geus and Laurence Decerf.

Directors

According to the 2025 annual accounts

Christophe Geus

Director

Laurence Decerf

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Gaston Delvaux 100

1450 Chastre

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0832.964.833
VAT number: BE 0832.964.833
Registered office: Rue Gaston Delvaux 100, 1450 Chastre
Names & denominations: MED GEUS-DECERF
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 January 2011
Peppol: Active · Active since 24 Nov 2023
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗